# STOPGAP (NCT04762953)

> Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04762953
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: University of California, Irvine
- Conditions: Gastric Cancer; Peritoneal Carcinomatosis; Gastroesophageal Junction Adenocarcinoma
- Interventions: Paclitaxel; Paclitaxel; Leucovorin; Fluorouracil
- Enrollment: 40
- Primary outcome: Participants with Progression Free Survival at 1-Year
- Primary outcome: Incidence of Treatment-Emergent Adverse Events [Safety]

## Commentary we found

- YouTube: 8
- Podcasts: 7
- X threads: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=stopgap-nct04762953

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04762953", "email": "<work email>"}; the inbox owner confirms by the emailed link.